Book a Meeting

Anti-Rabies virus Antibody, Non-Fucosylated (BioBet-421ZP) (CAT#: BioBet-421ZP) Datasheet

Target
Rabies virus
Isotype
IgG
Description
ADCC-enhanced Foravirumab is a non-fucosylated anti-Rabies virus therapeutic biobetter antibody.
Antibody Indication
Rabies post-exposure ( use in combination (Prophylaxis))
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Rabies virus antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
Rabies Virus Glycoprotein
Alternative Names
Rafivirumab;944548-37-2;CR57;rabies virus;rabies virus glycoprotein
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
Foravirumab
Host
Human
Species Reactivity
Rabies virus
Description
ADCC-enhanced Foravirumab is a non-fucosylated anti-Rabies virus therapeutic biobetter antibody.
Antibody Indication
Rabies post-exposure ( use in combination (Prophylaxis))

Rabies post-exposure ( use in combination (Prophylaxis))

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.